Literature DB >> 27663964

A 10-Year Review of Necrotizing Fasciitis in the Pediatric Population: Delays to Diagnosis and Management.

Heather VanderMeulen1, Jeffrey M Pernica2, Madan Roy2, April J Kam2.   

Abstract

OBJECTIVE: To assess the promptness and appropriateness of management in pediatric cases of necrotizing fasciitis (NF).
METHODS: A retrospective chart review examined cases of pediatric NF treated at a pediatric tertiary care center over a 10-year period.
RESULTS: Twelve patients were identified over the 10-year period. The median (25th to 75th centile) times to appropriate antibiotic administration, infectious disease consults, surgical consults and debridement surgeries were 2.6 (2.1-3.2), 7.7 (3.4-24.4), 4.6 (1.7-21.0), and 22.1 (10.3-28.4) hours following assessment at triage. The initial antibiotic(s) administered covered the causative organism in 9 of 12 cases. The median (25th to 75th centile) length of hospital stay was 21 (14.0-35.5) days.
CONCLUSIONS: The large variability in the care of these patients speaks to the range of their presenting symptomatology. The lack of a standardized approach to the pediatric patient with suspected NF results in delays in management and suboptimal antibiotic choice.

Entities:  

Keywords:  emergency medicine; necrotizing fasciitis; pediatric; quality improvement; soft tissue infection

Mesh:

Substances:

Year:  2016        PMID: 27663964     DOI: 10.1177/0009922816667314

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


  2 in total

1.  A 30-Day-Old Infant with Necrotizing Fasciitis of the Perineal Region Involving the Scrotum Due to Methicillin-Resistant Staphylococcus aureus (MRSA) and Extended-Spectrum β-Lactamase (ESBL)-Producing Klebsiella pneumoniae: A Case Report.

Authors:  Edi Hartoyo; Fabiola Vania Felicia
Journal:  Am J Case Rep       Date:  2022-09-28

2.  Necrotizing fasciitis after scrotum skin injury in an infant: A case report.

Authors:  Z X Ren; C L Liu; Q Zhang; F Xu; Y N Zheng; X J Li; J Yang
Journal:  Medicine (Baltimore)       Date:  2018-03       Impact factor: 1.889

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.